- Open Access
Quality of life among cancer inpatients 80 years and older: a systematic review
Health and Quality of Life Outcomes volume 19, Article number: 98 (2021)
The aim of this systematic review was to summarize and assess the literature on quality of life (QoL) among cancer patients 80 years and older admitted to hospitals and what QoL instruments have been used.
We searched systematically in Medline, Embase and Cinahl. Eligibility criteria included studies with any design measuring QoL among cancer patients 80 years and older hospitalized for treatment (surgery, chemotherapy or radiation therapy). Exclusion criteria: studies not available in English, French, German or Spanish. We screened the titles and abstracts according to a predefined set of inclusion criteria. All the included studies were assessed according to the Critical Appraisal Skills Programme checklists, and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement checklist was used to ensure rigor in conducting and reporting. This systematic review was registered in PROSPERO (CRD42017058290).
We included 17 studies with 2005 participants with various cancer diagnoses and Classification of Malignant Tumors stages (TNM). The included studies used a range of different QoL instruments and had different aims and outcomes. Both cancer-specific and generic instruments were used. Only one of the 17 studies used an age-specific instrument. All the studies included patients 80 years and older in their cohort, but none specifically analyzed QoL outcomes in this particular subgroup. Based on findings in the age-heterogeneous population (age range 20–100 years), QoL seems to be correlated with the type of diagnosed carcinoma, length of stay, depression and severe symptom burden.
We were unable to find any research directly exploring QoL and its determinants among cancer patients 80 years and older since none of the included studies presented specific analysis of data in this particular age subgroup. This finding represents a major gap in the knowledge base in this patient group. Based on this finding, we strongly recommend future studies that include this increasingly important and challenging patient group to use valid age- and diagnosis-specific QoL instruments.
The number of people aged 80 years and older is expected to increase in Europe , and with advancing age the risk of being diagnosed with cancer increases: 36% of all men and 29% of all women older than 75 years are currently diagnosed with cancer . An increase in the total number of cancer cases among people 80 years and older means that more in-hospital cancer treatment will be required. In 2018, 25,444 (11,4%) people aged 80 years and older were hospitalized because of cancer in Norway . The main causes of hospital admission were cancer progression, cancer-related signs and symptoms (febrile neutropenia, infection, pain, fever and dyspnea), treatment-related complications and end-of-life support [3, 4].
The World Health Organization (WHO) defines quality of life (QoL) as “an individual’s perception of their position in life, in the context of the culture in which they live and in relation to their goals, expectations, standards and concerns” . Currently, the term QoL is often used interchangeably with health-related QoL (HRQoL) and is measured by the scores of either a generic or disease-specific QoL questionnaire . Generic means a general questionnaire regardless of the illness or condition of the patient, whereas disease-specific instruments focus on the issues of particular concern to patients with the disease [9, 10]. Generic and disease-specific questionnaires are generally accepted as multidimensional assessments of how disease and treatment affect a patient’s sense of overall functioning and well-being . Padilla et al.  defined HRQoL as “a personal, evaluative statement summarizing the positivity or negativity of attributes that characterize one’s psychological, physical and social functioning, and spiritual well-being at a point in time when health, illness, and treatment conditions are relevant” (p 301–308). Most QoL instruments developed over the past 10 years reflect elements of the approach advocated by Padilla et al. . This systematic review uses the term QoL, thus indicating a relatively broad definition of QoL. Since there is no clarity about the term QoL and different instruments are used to measure QoL for older cancer patients , this systematic review is therefore indicated to provide clarity in this particular area, and identify future research endeavors.
Chronic disease-related symptoms such as fatigue , vomiting, nausea, anxiety, depression  and pain [5, 15] are common among older cancer patients and further challenge care management. The presence of multiple symptoms and comorbidity was found to be associated with decreased functional status and QoL in cancer patients [13, 14, 16, 17].
A recent systematic review of studies conducted with hospitalized patients undergoing active treatment for cancer or receiving palliative care found that older patients had more adverse health-related outcomes, including more functional dependence, mental distress, and depression, longer hospital stays and higher mortality than younger patients . The presence of multiple symptoms and comorbidity were shown to be associated with decreased functional status and quality of life [13, 14, 16, 17].
Given the multiple symptoms and other challenges such as multimorbidity, polymedication [18, 19] and reduced tolerance for treatment among people aged 80 years and older with cancer, it could be argued that the experience of being hospitalized combined with treatment will adversely affect these patients’ QoL. Accurate diagnosis and appropriate care and treatment of cancer-related problems can improve patients’ QoL . Nevertheless, existing models of health care do not currently meet the needs and expectations of this group of patients very well .
To the best of our knowledge, a systematic review exploring QoL among cancer inpatients 80 years and older has not yet been published. We found only one systematic review of QoL during and after cancer therapy among patients 65 years and older, but that study only included patients with colon cancer , thus limiting the generalizability to patients with others types of cancer. Individual studies have reported QoL and its determinants by cancer diagnosis in homogeneous groups of older patients, but to date no attempt has been made to systematically evaluate or compare findings across studies among cancer inpatients 80 years and older. This knowledge is essential for facilitating the best possible treatment and care for the elderly cancer patients in hospital. In this systematic review, we explored the following research question:
In studies that included cancer inpatients undergoing treatment aged 80 years and older, how was quality of life measured and reported in this specific subgroup?
This review is registered on PROSPERO  and was conducted using the Preferred Reporting Items for Systematic Reviews and Analysis (PRISMA) checklist  to ensure rigor in conducting and reporting.
Eligible studies were those published and which examined QoL among patients aged 80 years and older who were undergoing cancer treatment. Cancer treatment was defined as surgery, chemotherapy and radiation therapy. Studies that covered heterogeneous age groups were included if the study included participants 80 years and older. Eligible studies used any design. Eligible studies were those that were available in English, French, German or Spanish. We did not include gray literature, unpublished studies, ongoing clinical trials, theses or dissertations. Studies with low quality were ineligible for inclusion in the systematic review.
The following electronic bibliographic sources were searched: Medline (OvidSP 1946–present), Embase (OvidSP 1974–present), and Cinahl (Ebscohost 1981–present). The search was completed in July 2019. The search terms included cancer, hospitalization, elderly patients and quality of life (Fig. 1). Our PICO (population, intervention, comparison and outcome) parameters included cancer patients aged 80 years and older as our population. Our outcome was measures of QoL. The search was created to capture all studies investigating quality of life of older cancer inpatients undergoing cancer treatment. The search strategy was based on the search filter created by Semple et al. . Figure 1 shows the complete search history in a PRISMA flow chart.
We screened all search results by title and abstract using Rayyan software . Two reviewers independently determined the eligibility of all articles by reading the titles and abstracts. The reviewers resolved any disagreement on inclusion or exclusion through discussion. A third reviewer was available if the disagreement could not be resolved. Further, if the title and abstract did not contain enough information to assess eligibility, we screened the full text of the article. Then, in pairs of reviewers (JD & RS and EGB & LE), we screened the full text of each eligible article.
We developed a data extraction form that enabled us to extract the following data: (1) the author, year and country of publication; (2) the aim or objective of the study; (3) the design and setting; (4) the participants and control group; (5) the QoL instrument used in the study; and (6) the primary results of the study and the authors’ conclusions. The reviewers (EGB, JD, LSPE and RMS) independently extracted the data and double-checked each other’s data. The reviewers resolved any disagreement about data extraction by discussion.
We assessed the quality of the 17 included articles by using the Critical Appraisal Skills Programme (CASP), which comprises checklists adapted to the various study designs. The reviewers independently evaluated each article and resolved disagreements by consensus. Critical assessment of the studies was graded according to different design-specific CASP checklists, from 25% of criteria met, 50% of criteria met, 75% of criteria met to 100% of criteria met CASP checklists [24, 25]. The last column of Table 1 reports the result of each study. Studies were appraised as having high quality when 100% of the criteria were met. Studies were classified as having a risk of low quality when 25% of criteria were met and were excluded from the systematic review. The main methodological drawbacks were reported.
Data synthesis and analysis
The included studies differed in study design, cancer population, QoL instruments and statistical analysis used, and the results were therefore synthesized narratively (Table 1).
We included 17 studies that had patients aged 80 years and older in their cohorts. Since none of the studies presented estimates of QoL in this particular subgroup of patients, no direct evidence was found on QoL among cancer inpatients aged 80 years and older. Only one of the included studies used an age-specific QoL instrument.
We pooled the search results from the three databases. The review group screened 2953 titles and abstracts according to a predefined set of inclusion criteria, found 84 eligible studies, screened them in full text and excluded 67 of these. The primary reason for exclusion at this stage was the fact that patients 80 years and older were not included or that QoL was not measured (Fig. 1).
Characteristics of the included studies
This review included 2005 participants from 11 countries. Most of the studies were conducted in the United States (n = 5), followed by China and Japan (n = 2). In studies that provided information on participants’ ages, the ages ranged from 20  to 100 years , and only two studies stated how many participants were older than 80 years. No studies analyzed QoL outcomes in the subgroup of patients aged 80 years and older. The duration of the study periods ranged from 7 days to 31 months. The sample sizes ranged from 32 to 455. The studies used retrospective (n = 1) and prospective (n = 10) cohorts and cross-sectional (n = 6) designs. Twelve of the studies included only hospitalized patients [20, 24, 25, 27,28,29,30,31,32,33,34,35], and one study included both hospital- and home-based patients . Two studies included inpatients in the palliative care unit in the hospital who were undergoing cancer treatment [37, 38], and one study included patients from palliative home care services and the palliative unit of a hospital . One study  was a multicenter study from 11 cancer centers and a university hospital (Table).
Instruments used to measure QoL
QoL instruments are categorized as either disease-specific or generic or overall . Most (n = 11) of the 17 studies used disease-specific instruments to measure QoL in cancer [20, 25, 27,28,29, 31, 33, 36, 38,39,40]. The disease-specific instruments included European Organization for Research and Treatment (EORTC) Quality of Life Questionnaire Core 30 (EORTC-QLQ-C30) [20, 28, 29, 33, 36, 39, 40], EORTC Quality of Life Care Palliative 15 (EORTC QLO-C15 PAL) [27, 38, 40], EORTC Quality of Life esophagus cancer version (EORTC QLQC30-OES-18)  and EORTC Quality of Life pancreas version (EORTC-QLQ-PAN- 26) . In addition to the EORTC QoL instruments, some studies used other disease-specific QoL instruments, including the Functional Assessment of Cancer Therapy – Leukemia (FACT-Leuk) [24, 34] and the Functional Assessment of Cancer Therapy – Colorectal Cancer (FACT-C) instruments [20, 24] and the Functional Assessment of Cancer Therapy Fatigue (FACT-Fatigue)  and Quality of Life Patient/Cancer Survivor (QoL-CS) version.
Three of the 17 studies used generic instruments [32, 34, 37]. The generic QoL instruments were WHOQOL-BREF [32, 37], PROMIS Global Health  and WHOQOL-OLD , which has been validated for use with older people. One study used a generic QoL instrument comprising the single item “Overall, how would you presently rate your own life?” .
None of the included studies reported on patients’ spiritual QoL domain, regardless of the study sample’s age.
How quality of life was reported in the subpopulation of cancer patients older than 80 years
QoL was not estimated among the subgroup of inpatients older than 80 years of age in any of the studies, even though this specific subgroup was represented in all study samples.
How quality of life was reported in the populations studied (age range 20–100 years)
A study of the incidence of pancreatic cancer–related depression among inpatients with cancer found that the type of carcinoma in the digestive system (pancreatic, liver, esophageal, gastric and colorectal) and symptoms of depression were negatively correlated with QoL, as measured by the EORTC-QLQ-PAN-26 questionnaire , QoL domains (global health status, physical functioning and emotional functioning) measured by QLQ-C15-PAL predict survival among 162 inpatients with advanced cancer . In a study of the effectiveness of palliative care during the end of life of cancer inpatients with prostate and lung cancer, found that QoL, as measured by QLQ-C15-PAL, was correlated with the type of diagnosed carcinoma . In that study, patients with lung cancer had lower QoL than patients with colon cancer.
In a study comparing one palliative care unit in a general hospital and 10 palliative home care services, the terminally ill cancer inpatients had a statistically significant and clinically relevant decrease in nausea and vomiting pain and dyspnea compared with the terminally ill cancer patients in home care services . Two studies identified quality of life as higher among patients with lower lengths of hospital stays [26, 28]. Postoperatively, patients (with esophageal and gastroesophageal junction cancer) with length of hospital stays < 10 days had significantly better QoL scores in the functional scales (physical, emotional, social and role functioning) and in symptom scales (fatigue, nausea, dyspnea, appetite loss and dry mouth) at 3 and 12 months compared with patients with a length of stay > 10 days . Lower pretreatment QoL (as measured by FACT-C) was significantly correlated with increased length of stay among inpatients undergoing surgery for colorectal cancer .
Terminally ill cancer inpatients in a palliative care center had statistically significantly more symptom severity and distress, higher depression score and worse physical health and QoL than the terminally ill cancer patients receiving home-based services .
Low QoL and severe symptom burden, especially fatigue and appetite loss, were observed among the inpatients with malignant disease in one study . Patients with instrumental activities of daily living (IADL) dysfunction at baseline were more likely to have reduced QoL on role and social functioning after radiation therapy compared with patients without IADL dysfunction .
Shinozaki et al.  found no significant relationship between QoL scores and functional status among terminally ill inpatients with head and neck cancer, and depressed inpatients with lung cancer had significant worse physical, mental, social and environmental QoL than patients who were not depressed . The age groups did not differ statistically significantly in global QoL among inpatients with bone metastasis, as measured by the single-item questionnaire .
Further, the symptoms of fatigue, anxiety and sleep disturbance were associated with reduced QoL among adult inpatients with acute leukemia , and QoL was reported to be poor among 41% of the 29 inpatients with high scores in activities of daily living who had undergone total gastrectomy for cancer . QoL was not significantly associated with functional status in a study of terminally ill inpatients with head and neck cancer . All these results are based on analyses of age-heterogeneous cancer inpatients 20–100 years of age.
Methodological quality of the included studies
Overall, all 17 included studies had high to medium methodological quality according to the CASP assessment and met at least 9 of 12 criteria on the checklists (high quality) (Table 1, last column). The main methodological drawbacks of the included studies were related to question 5 on confounding factors. Eight of the 17 studies did not indicate if they had controlled for confounding factors [25, 27,28,29, 33, 34, 36, 39], creating difficulty in drawing conclusions on the validity of the results. Five of the studies [26, 27, 34, 35, 39] had limitations related to question 8 on the confidence interval estimate of the HRQoL or QoL outcome. Two of the studies did not report receiving approval by an ethics committee [37, 38].
Although the 17 studies included in this systematic review did not report QoL specifically among cancer inpatients aged 80 years and older, they all included participants in this age group. The studies represent different study designs, age and cancer populations, measurement scales and outcomes. The results of this review nevertheless provide some indirect insights that will contribute to improving the understanding of QoL among patients aged 80 years and older admitted to hospital. The results of this review identified that almost all studies (n = 10) measured QoL using instruments that do not measure all aspects of QoL (mental, physical, social and spiritual well-being) as defined by Padilla et al. .
The spiritual domain would be especially important to measure among cancer inpatients older than 80 years, since they are approaching the final stage of their life and have a severe disease. Nevertheless, this domain was only included in two instruments used: WHOQOL-OLD  and the Quality of Life Index . The articles did not present the results of the analysis of the spiritual domain. Further, the EORTC QLQ-C15-PAL, which does not include the spiritual domain, was used in studies of advanced cancer and terminally ill patients [27, 38, 40]. Spiritual well-being is relevant for older patients undergoing cancer treatment and receiving palliative care . QoL measures should therefore be complemented by questionnaires that include spirituality to aid health care providers in better facilitating the patients’ individual needs at the end of life. The finding that QoL among cancer patients aged 80 years and older has not been investigated with validated diagnosis- and age-specific instruments is important because evidence is needed to inform the development of appropriate health care services for this group of patients.
Hospital patients reported worse physical health, QoL and symptom burden than those in home care services [36, 39] this is due to more severe cases being hospitalized. Symptoms among older patients with cancer are often reported measured with highly relevant measurement instruments for cancer patients [3,4,5, 13]. However, severe symptoms may reduce patients’ overall QoL because of distress .
For older patients with cancer, preoperative QoL, as measured with EORTC-QLQ C30  and FACT-C , is beneficial in predicting the length of hospital stay for different types of cancer. Holloway et al.  reported a significant association between lower FACT-C score and increased length of stay, where Nafteux et al.  reported that QoL, especially poor physical functioning, was an independent prognostic factor for longer hospital stay.
Only two of the studies [31, 35] provided information on Classification of Malignant Tumors TNM staging. One would assume that a large tumor size would inversely correlate with QoL scores. In a recent study of patients with renal tumors, preoperative tumor size did not correlate significantly with self-reported QoL. However, the exception was that patients with the largest tumors (> 7.0 cm) reported significantly worse general health and QoL (questions 29 and 30 in the QLQ-C30 questionnaire) . Studies of head and neck cancer patients identified that tumor size does not correlate with self-reported QoL . Nevertheless, these results are in accordance with the study by Vissers et al.  that found that, regardless of cancer type, comorbidity explains more of the variance in QoL than tumor size.
Comorbidities are important factors that often characterize patients aged 80 years and older [16, 46], which in turn may affect their QoL . We expected that comorbidities could be a plausible confounding factor for older people, but only a few studies highlighted this issue [27, 38, 39, 47].
Another important finding of this review was that older patients reported higher levels of pain and received significantly fewer opioids for their cancer-related pain than middle-aged patients, but their overall QoL did not differ significantly . However, global QoL scales provide no information on the different dimensions of QoL, and older patients with higher levels of pain may therefore have differed from middle-aged patients with lower levels of pain on specific dimensions of QoL. Since cancer pain reduces the QoL of older patients and impairs their physical functioning, sleep, activities of daily living, life enjoyment and mood , the measurement of QoL among older cancer patients needs to be investigated along all the dimensions of QoL to better understand and meet their care needs. In future studies, multidimensional scales such as the EORTC-QLQ-ELD  should be used to obtain information on the dimensions of QoL scales among older people.
Strengths and limitations of the review
Our review included studies reported in several languages, including English, French, German and Spanish. All 17 studies used QoL as primary outcome. Several methodological issues limit the conclusions of this review. All the included studies had different designs, aims and outcomes. Our review included studies that reported a wide age range (20–100 years) and highlighted the fact that none of the studies reported separate statistical analysis for people 80 years and older. This limitation makes it difficult to understand how patients aged 80 years and older experience their QoL during cancer treatment. Older people are expected to rate their QoL differently from younger people, and different domains of QoL, such as the spiritual domain, are more or less important in different age groups.
The prospective studies show great variation in the sample sizes, from 32  to 455 included participants . The heterogeneity of the questionnaires used to assess QoL makes comparing the results difficult. We found that no studies examined QoL in patients with specific cancer diagnoses. Hence, including different cancer diagnoses in one review might even increase the external validity.
For cost reasons and to ensure the quality warranted by a peer-review process, we did not search gray literature, unpublished studies, ongoing clinical trials, theses or dissertations. We did not include studies written in Chinese, Japanese or Russian.
This review included 17 studies investigating QoL among cancer inpatients 80 years and older. Several QoL instruments were used, and only one study used an age-specific instrument. None of the studies specifically analyzed QoL outcomes among patients 80 years and older. Therefore, no firm conclusion can be drawn regarding the evidence on the QoL of cancer inpatients 80 years and older. This finding represents a major gap in the knowledge base in the cancer literature. Based on this finding, we strongly recommend future studies in this increasingly important and challenging patient group using valid age- and diagnosis-specific instruments and conducting subgroup analysis for patients 80 years and older.
Availability of data and materials
quality of life
critical appraisal skills programme
activities of daily living
brief pain inventory
clinical index of pain management
eastern cooperative oncology group
European organisation for research and treatment of cancer
functional assessment of cancer therapy– Leukemia
functional assessment of cancer therapy – colorectal cancer
functional assessment of cancer therapy – Fatigue
esophageal cancer module, 18 items
global health patient reported outcome measure global health
quality of life questionnaire core 15 for palliative care
quality of life questionnaire core 30 for palliative care
quality of life patient/cancer survivor version
- QLQ-PAN- 26:
quality of life questionnaire core 26 for pancreatic cancer
world health organization quality of life questionnaire – brief version
world health organization quality of life questionnaire for older adults
WHO. Ageing and health. Geneva: World Health Organization; 2017.
Statistics Norway. www.ssb.no. Accessed 7 December 2020.
Yucel N, Sukru Erkal H, Sinem Akgun F, Serin M. Characteristics of the admissions of cancer patients to emergency department. J BUON. 2012;17(1):174–9.
Vandyk AD, Harrison MB, Macartney G, Ross-White A, Stacey D. Emergency department visits for symptoms experienced by oncology patients: a systematic review. Support Care Cancer. 2012;20(8):1589–99.
Dotan E, Browner I, Hurria A, Denlinger C. Challenges in the management of older patients with colon cancer. J Natl Compr Canc Netw. 2012;10(2):213–25.
Bouras AF, Ioos E, Aoudia A, Kaci H, Benaibouche D, Merad-Boudia F. The vision and role of geriatric oncology in surgical treatment of the elderly patient. J Visc Surg. 2019;156(1):37–44.
The WHO QOL Group. The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41(10):1403–9.
Semple CJ, Sullivan K, Dunwoody L, Kernohan WG. Psychosocial interventions for patients with head and neck cancer: past, present, and future. Cancer Nurs. 2004;27(6):434–41.
Scotté F, Bossi P, Carola E, Cudennec T, Dielenseger P, Gomes F, et al. Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide. Ann Oncol. 2018;29(8):1718–26.
Haraldstad K, Wahl A, Andenæs R, Andersen JR, Andersen MH, Beisland E, et al. A systematic review of quality of life research in medicine and health sciences. Qual Life Res. 2019;28(10):2641–50.
Fayers PM, Machin D. Quality of life: the assessment, analysis and reporting of patient-reported outcomes. New York: John Wiley & Sons; 2016.
Padilla GV, Grant MM, Ferrell BR, Presant CA. Quality of life – cancer. In: Spilker B, ed. Philadelphia: Lippincott-Raven; 1996.
Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, et al. Cancer-related fatigue, Version 2.2015. J Natl Compr Canc Netw. 2015;13(8):1012–39.
Rao A, Cohen HJ. Symptom management in the elderly cancer patient: fatigue, pain, and depression. J Natl Cancer Inst Monogr. 2004;32:150–7.
Maione P, Rossi A, Sacco PC, Bareschino MA, Schettino C, Ferrara ML, et al. Treating advanced non-small cell lung cancer in the elderly. Ther Adv Med Oncol. 2010;2(4):251–60.
Fabbri E, Zoli M, Gonzalez-Freire M, Salive ME, Studenski SA, Ferrucci L. Aging and multimorbidity: new tasks, priorities, and frontiers for integrated gerontological and clinical research. J Am Med Dir Assoc. 2015;16(8):640–7.
Astrup GL, Hofso K, Bjordal K, Guren MG, Vistad I, Cooper B, et al. Patient factors and quality of life outcomes differ among four subgroups of oncology patients based on symptom occurrence. Acta Oncol. 2017;56(3):462–70.
Molokhia M, Majeed A. Current and future perspectives on the management of polypharmacy. BMC Fam Pract. 2017;18(1):70.
Lees J, Chan A. Polypharmacy in elderly patients with cancer: clinical implications and management. Lancet Oncol. 2011;12(13):1249–57.
Jia L, Jiang SM, Shang YY, Huang YX, Li YJ, Xie DR, et al. Investigation of the incidence of pancreatic cancer–related depression and its relationship with the quality of life of patients. Digestion. 2010;82(1):4–9.
Drageset J, Beisland EG, Austrheim G, Sandvik RK, Eide LP, Fox M. Octogenarian cancer patients in somatic hospitals: a systematic review. York: PROSPERO; 2017. https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=58290. Accessed 7 December 2020.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). http://www.prisma-statement.org. Accessed 7 December 2020.
Rayyan QCRI. https://rayyan.qcri.org/welcome. Accessed 7 December 2020.
El-Jawahri A, Abel GA, Traeger L, Waldman L, Markovitz N, VanDusen H, et al. Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapy. Leukemia. 2019;33(10):2393–402.
Holloway S, Sarosi G, Kim L, Nwariaku F, O’Keefe G, Hynan L, et al. Health-related quality of life and postoperative length of stay for patients with colorectal cancer. J Surg Res. 2002;108(2):273–8.
CASP checklists. https://casp-uk.net/casp-tools-checklists. Accessed 7 December 2020.
Jasinska M, Tracz M, Kurczewska U, Orszulak-Michalak D. Assessment of change of quality of life in hospitalized terminally ill cancer patients. Wspolczesna Onkol. 2010;14(5):333–9.
Nafteux P, Durnez J, Moons J, Coosemans W, Decker G, Lerut T, et al. Assessing the relationships between health-related quality of life and postoperative length of hospital stay after oesophagectomy for cancer of the oesophagus and the gastro-oesophageal junction. Eur J Cardiothorac Surg. 2013;44(3):525–33.
Stromgren AS, Niemann CU, Tange UB, Farholt H, Sonne NM, Ankersen L, et al. Quality of life and symptoms in patients with malignant diseases admitted to a comprehensive cancer centre. Supp Care Cancer. 2014;22(7):1843–9.
Torvik K, Holen J, Kaasa S, Kirkevold O, Holtan A, Kongsgaard U, et al. Pain in elderly hospitalized cancer patients with bone metastases in Norway. Int J Palliat Nurs. 2008;14(5):238–45.
Ishihara K. Long-term quality of life in patients after total gastrectomy. Cancer Nurs. 1999;22(3):220–7.
Gu W, Xu YM, Zhu JH, Zhong BL. Depression and its impact on health-related quality of life among Chinese inpatients with lung cancer. Oncotarget. 2017;8(62):104806–12.
VanderWalde NA, Deal AM, Comitz E, Stravers L, Muss H, Reeve BB, et al. Geriatric assessment as a predictor of tolerance, quality of life, and outcomes in older patients with head and neck cancers and lung cancers receiving radiation therapy. Int J Radiat Oncol Biol Phys. 2017;98(4):850–7.
Leak Bryant A, Reeve BB, Gosselin T, Coffman EM, Phillips B, Gray TF, et al. Symptoms, mobility and function, and quality of life in adults with acute leukemia during initial hospitalization. Oncol Nurs Forum. 2018;45(5):653–64.
Alaloul F, Myers J, Masterson KM, DiCicco J, Perry Collins M, Hogan F, et al. Patient experience factors and health-related quality of life in hospitalized individuals. Oncol Nurs Forum. 2019;46(2):238–47.
Peters L, Sellick K. Quality of life of cancer patients receiving inpatient and home-based palliative care. J Adv Nurs. 2006;53(5):524–33.
Wittmann-Vieira R, Goldim JR. Bioethics and palliative care: decision making and quality of life. Acta Paul Enferm. 2012;25(3):334–9.
Lee YJ, Suh SY, Choi YS, Shim JY, Seo AR, Choi SE, et al. EORTC QLQ-C15-PAL quality of life score as a prognostic indicator of survival in patients with far advanced cancer. Supp Care Cancer. 2014;22(7):1941–8.
Jocham HR, Dassen T, Widdershoven G, Middel B, Halfens R. The effect of palliative care in home care and hospital on quality of life. J Hosp Palliat Nurs. 2009;11(2):119–26.
Shinozaki T, Ebihara M, Iwase S, Yamaguchi T, Hirakawa H, Shimbashi W, et al. Quality of life and functional status of terminally ill head and neck cancer patients: a nation-wide, prospective observational study at tertiary cancer centers in Japan. Jpn J Clin Oncol. 2017;47(1):47–53.
Fayers P, Machin D. Quality of life: the assessment, analysis and interpretation of patient-reported outcomes: New York: John Wiley & Sons; 2013.
McClain CS, Rosenfeld B, Breitbart W. Effect of spiritual well-being on end-of-life despair in terminally-ill cancer patients. Lancet. 2003;361(9369):1603–7.
Beisland E, Hauge EM, Aarstad AKH, Hjermstad MJ, Aarstad HJ, Beisland C. Personality and educational level determine self-reported health-related quality-of-life and distress in patients with renal tumors awaiting radical surgery. Scand J Urol. 2020:1–9.
Aarstad AK, Beisland E, Aarstad HJ. Personality, choice of coping and T stage predict level of distress in head and neck cancer patients during follow-up. Eur Arch Otorhinolaryngol. 2012;269(9):2121–8.
Vissers PA, Thong MS, Pouwer F, Zanders MM, Coebergh JW, van de Poll-Franse LV. The impact of comorbidity on health-related quality of life among cancer survivors: analyses of data from the PROFILES registry. J Cancer Surviv. 2013;7(4):602–13.
Beard JR, Officer A, de Carvalho IA, Sadana R, Pot AM, Michel JP, et al. The world report on ageing and health: a policy framework for healthy ageing. Lancet. 2016;387(10033):2145–54.
Cheng KK, Lee DT. Effects of pain, fatigue, insomnia, and mood disturbance on functional status and quality of life of elderly patients with cancer. Crit Rev Oncol Hematol. 2011;78(2):127–37.
Wheelwright S, Darlington AS, Fitzsimmons D, Fayers P, Arraras JI, Bonnetain F, et al. International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer. Br J Cancer. 2013;109(4):852–8.
This work was carried out without any funding.
Ethics approval and consent to participate
Consent for publication
Each author participated sufficiently in the work to take public responsibility for appropriate portions of the content. All authors agreed to be personally accountable for the author's own contributions and to ensure that questions related to the accuracy of any part of the work, even ones in which the author was not personally involved, are appropriately investigated, resolved, and the resolution documented in the literature.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Drageset, J., Sandvik, R.K., Eide, L.S.P. et al. Quality of life among cancer inpatients 80 years and older: a systematic review. Health Qual Life Outcomes 19, 98 (2021). https://doi.org/10.1186/s12955-021-01685-0
- Quality of life
- 80 years and older
- Cancer inpatient
- Somatic hospitals
- Systematic review